Slingshot Insights | 6540.two Overview

6540.TWO Overview

Upcoming Projects (6540.TWO)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (6540.TWO)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (6540.TWO)

JHL Biotech Receives Approval From European Authorities to Begin JHL1101 Rituximab Biosimilar Clinical Trial and is the First Biotech Company in Greater China Region to Receive European Approval
Tickers: 6540.TWO, RHHBY
Occurred on: Feb 15, 2016

Strategic Initiatives (6540.TWO)

Don’t see a strategic initiative related to the company you care about? Create your own!